Jazz Pharmaceuticals
JAZZ
JAZZ
389 hedge funds and large institutions have $7.73B invested in Jazz Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 118 increasing their positions, 156 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
4.01% more ownership
Funds ownership: 94.28% → 98.29% (+4%)
2% more funds holding
Funds holding: 383 → 389 (+6)
24% less repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 156
Holders
389
Holding in Top 10
6
Calls
$112M
Puts
$99.9M
Top Buyers
| 1 | +$304M | |
| 2 | +$169M | |
| 3 | +$94.7M | |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
+$63.5M |
| 5 |
Holocene Advisors
New York
|
+$48.6M |
Top Sellers
| 1 | -$89.1M | |
| 2 | -$77M | |
| 3 | -$54.7M | |
| 4 |
Two Sigma Investments
New York
|
-$36.1M |
| 5 |
Goldman Sachs
New York
|
-$32.2M |